SUBSCRIBE
SUBSCRIBE
Gail Dutton

Gail Dutton

Freelance writer

Gail Dutton is a veteran biopharmaceutical reporter, covering the industry from Washington state. You can contact her at gaildutton@gmail.com and see more of her work on Muckrack.

Policy
Disruptive Innovation: Ready, Willing and Able to Deliver Quality Therapeutics at Speed
Drug development can be done better, faster and less expensively. The industry is facing up to that reality, moving a variety of disruptive innovations forward with the blessing of regulators.
August 21, 2022
 · 
6 min read
 · 
Gail Dutton
Courtesy of Fabian Sommer/Picture Alliance via Get
Drug Development
Paxlovid Rebound: RWE Analysis and Alternative Therapies in Development
Researchers at Case Western University looked at the real-world experiences of 13,644 patients who were treated with Paxlovid or Lagevrio (molnupiravir) during the first half of 2022.
August 17, 2022
 · 
5 min read
 · 
Gail Dutton
Deals
Investors Continue to Fund Data Over Ideas In Current Biotech Downturn
BioSpace spoke with industry executives and investors about the current economic situation in the biotech industry and sourced tips on how leaders can weather the downturn.
August 16, 2022
 · 
4 min read
 · 
Gail Dutton
Drug Development
Why is the Quest for Universal Flu and COVID-19 Vaccines Taking so Long?
After more than two decades of attempts to develop a universal influenza vaccine, the global COVID-19 pandemic intensified the need for a broader vaccine for both illnesses.
August 15, 2022
 · 
4 min read
 · 
Gail Dutton
Unpacking the Conundrum of the High Cost of Healthcare
Healthcare improvement leaders from Concordia University and Premier Inc. say the reasons behind the high cost of healthcare are multifaceted and point out the actual price of innovation.
August 10, 2022
 · 
5 min read
 · 
Gail Dutton
Digital therapeutics can help enhance the disease-
Digital Therapeutics can Increase Value of Disease-Modifying Drugs
Biogen and others are seeing the value in, particularly, non-prescription digital therapeutics, as complementary companion therapies to disease-modifying drugs.
August 9, 2022
 · 
5 min read
 · 
Gail Dutton
Drug Development
Tufts’ Ken Getz: Onerous Clinical Trial Protocols Contribute to High Failure Rates
Industry executives often lament the fact that clinical trials take a long time to complete and often fail. BioSpace spoke with Tufts’ Ken Getz about possible reasons and solutions.
August 8, 2022
 · 
5 min read
 · 
Gail Dutton
Theranos founder Elizabeth Holmes/Courtesy of Just
Policy
Theranos’ Epic Self-Destruction Offers Lessons for Biotech Companies
Whistleblowers Erika Cheung and Tyler Shultz discussed their experiences at Theranos during the recent 2022 AACC Annual Scientific Meeting & Clinical Lab Expo.
August 2, 2022
 · 
5 min read
 · 
Gail Dutton
As Psychedelic Therapies Advance, Regulators Must Weigh Results against Safety
BioSpace sat down with Katy Powell, a psychiatric mental health nurse practitioner in Portland, Oregon, to discuss the relative risks and benefits associated with psychedelic-assisted therapy.
August 1, 2022
 · 
6 min read
 · 
Gail Dutton
Deals
Biotech’s Prospects Transition from Hero to Zero and – Maybe – Back Again
The biotech industry is facing what some consider the worst times since its inception. Several market analysts recently shared their thoughts.
July 25, 2022
 · 
4 min read
 · 
Gail Dutton
Pictured: Chinese flags in a row/iStock
Why China’s Biotech Sector Thrives Despite a Global Recession
In 2000, China did not have one company on the Forbes Global 2000 list. In 2021, it had 14. This is good for second place on this list, behind the United States which had 31.
July 23, 2022
 · 
5 min read
 · 
Gail Dutton
Long structure of the DNA double helix in depth of view.
Drug Development
mRNA’s Next Act: Cancer Vaccines and Gene Editing
“The applications for mRNA are quite broad, because, basically, you are giving information to a cell to make any protein you want,” CureVac CFO Pierre Kemula told BioSpace.
July 22, 2022
 · 
4 min read
 · 
Gail Dutton
Monkeypox, A Member Of The Orthopox Family Of Viruses, Is An Infection Accidentally Transmitted To Humans Due To Its Similarity To The Smallpox Virus. Although Animals Infected With Monkeypox Exhibit No Symptoms, Infected Humans Manifest High Fever Accompanied By Headaches, Cervical And Inguinal Adenopathy, And Cutaneous Lesions That Are Similar To Those That Characterize A Smallpox Infection. As With Smallpox, No Effective Medical Treatment Has Been Identified. Here, The Arms And Legs Of A 4 Year Old Girl Infected With Monkeypox. Bondua, Grand Gedeh County, Liberia. (Photo By BSIP/UIG Via Getty Images)
Monkeypox: Experts Urge Caution, Surveillance but Stop Short of Declaring Emergency
As monkeypox continues to spread across the globe, health experts suggest monitoring vaccine effectiveness, population spread and at-risk groups.
July 20, 2022
 · 
5 min read
 · 
Gail Dutton
Business
How Not to Be a Token Board Member: Diversity in Leadership
To learn how women and underrepresented groups can secure seats on boards of directors, BioSpace spoke with perception analyst Dian Griesel and board member Terry Coelho.
July 17, 2022
 · 
5 min read
 · 
Gail Dutton
Will 90 be the New 40? Genomics and Precision Medicine Equal Longer Health Span
Recent advances in precision medicine and genomics have launched an explosion in immunotherapies that are resulting in real cures and earlier diagnoses - and more healthy years for individuals.
July 14, 2022
 · 
5 min read
 · 
Gail Dutton
Load More